Roy et al. (2006) compared the NAT2 gene polymorphism in 33 patients with pulmonary TB who developed drug-induced hepatotoxicity and 33 TB patients who did not develop drug-induced hepatotoxicity [25]. The gene discussed is NAT2; the disease is tuberculosis.